| Director/PDMR Shareholding | 06:00:14 | 24 May 2023 | |
| TETRIS PHARMA LAUNCHES OGLUO® IN DENMARK & NORWAY | 06:00:06 | 15 May 2023 | |
| ARECOR 2022 ANNUAL REPORT AND NOTICE OF AGM | 15:00:01 | 4 May 2023 | |
| Arecor Granted Key U.S Patent | 06:00:09 | 26 Apr 2023 | |
| Arecor on Investor Meet Company Platform | 06:00:04 | 21 Apr 2023 | |
| Unaudited Preliminary Results for 2022 | 06:00:58 | 20 Apr 2023 | |
| Arecor Appoints Chief Business Officer | 06:00:02 | 5 Apr 2023 | |
| FIRST PATIENT DOSED IN AT278 CLINICAL TRIAL | 07:00:02 | 22 Mar 2023 | |
| Price Monitoring Extension | 16:35:23 | 13 Mar 2023 | |
| Second Price Monitoring Extn | 14:05:22 | 13 Mar 2023 | |
| Price Monitoring Extension | 14:00:20 | 13 Mar 2023 | |
| Second Price Monitoring Extn | 11:05:38 | 13 Mar 2023 | |
| Price Monitoring Extension | 11:00:22 | 13 Mar 2023 | |
| Second Price Monitoring Extn | 09:05:41 | 13 Mar 2023 | |
| Price Monitoring Extension | 09:00:21 | 13 Mar 2023 | |
| ARECOR TO PRESENT SHARESOC WEBINAR | 07:00:12 | 1 Mar 2023 | |
| Holding(s) in Company | 16:44:40 | 24 Feb 2023 | |
| Notice of Results | 07:00:05 | 24 Feb 2023 | |
| Arecor Granted Patents in India and the US | 07:00:05 | 16 Feb 2023 | |
| ARECOR STRENGTHENS COLLABORATION WITH PARTNER | 07:01:01 | 14 Feb 2023 | |